ProfileGDS4718 / 225350_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 95% 97% 96% 95% 89% 91% 95% 96% 95% 94% 96% 91% 89% 89% 89% 94% 92% 88% 91% 96% 95% 93% 94% 93% 88% 96% 90% 93% 89% 91% 90% 94% 95% 87% 84% 92% 95% 93% 97% 93% 90% 92% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.015794
GSM549102patient 115, normal, homogenized [OPG study]10.237995
GSM549104patient 119, normal, homogenized [OPG study]11.174897
GSM549108patient 138, normal, homogenized [OPG study]10.484296
GSM549119patient 077, normal, homogenized [OPG study]10.288495
GSM549133patient 032, cancer, homogenized [OPG study]9.179789
GSM549139patient 042, cancer, homogenized [OPG study]9.2562391
GSM549099patient 107, normal, homogenized [OPG study]10.103895
GSM549109patient 139, normal, homogenized [OPG study]10.46696
GSM549110patient 046, normal, homogenized [OPG study]10.437495
GSM549114patient 063, normal, homogenized [OPG study]10.112894
GSM549122patient 082, normal, homogenized [OPG study]10.774296
GSM549134patient 033, cancer, homogenized [OPG study]9.3001191
GSM549136patient 036, cancer, homogenized [OPG study]9.1696689
GSM549140patient 044, cancer, homogenized [OPG study]9.1076589
GSM549111patient 047, normal, homogenized [OPG study]9.0881989
GSM549113patient 057, normal, homogenized [OPG study]10.100994
GSM549132patient 031, cancer, homogenized [OPG study]9.4964292
GSM549137patient 038, cancer, homogenized [OPG study]8.8161788
GSM549142patient 047, cancer, homogenized [OPG study]8.8489491
GSM549100patient 110, normal, homogenized [OPG study]10.432996
GSM549107patient 135, normal, homogenized [OPG study]10.429795
GSM549115patient 068, normal, homogenized [OPG study]10.090693
GSM549116patient 072, normal, homogenized [OPG study]10.055594
GSM549120patient 078, normal, homogenized [OPG study]9.8591393
GSM549131patient 030, cancer, homogenized [OPG study]9.0275588
GSM549118patient 074, normal, homogenized [OPG study]10.562196
GSM549129patient 027, cancer, homogenized [OPG study]9.1121290
GSM549123patient 088, normal, homogenized [OPG study]9.7940593
GSM549124patient 006, cancer, homogenized [OPG study]8.9609889
GSM549126patient 015, cancer, homogenized [OPG study]9.2277291
GSM549128patient 025, cancer, homogenized [OPG study]9.1924190
GSM549103patient 117, normal, homogenized [OPG study]9.8380394
GSM549117patient 073, normal, homogenized [OPG study]10.365495
GSM549138patient 041, cancer, homogenized [OPG study]8.7870887
GSM549141patient 045, cancer, homogenized [OPG study]8.4337484
GSM549130patient 028, cancer, homogenized [OPG study]9.3359592
GSM549101patient 111, normal, homogenized [OPG study]10.070195
GSM549105patient 128, normal, homogenized [OPG study]9.8208793
GSM549106patient 134, normal, homogenized [OPG study]10.915997
GSM549112patient 048, normal, homogenized [OPG study]9.9107393
GSM549125patient 011, cancer, homogenized [OPG study]9.1890890
GSM549127patient 024, cancer, homogenized [OPG study]9.4511892
GSM549135patient 035, cancer, homogenized [OPG study]9.4014191